Home
Search:
1146 feeds
357 categories
5802 articles (<24 hours)
24 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsPharmaMar announces that lurbinectedin has received acceptance for its clinical trial application in China
(WorldNews Belgium)

 
 

29 june 2020 14:57:14

 
PharmaMar announces that lurbinectedin has received acceptance for its clinical trial application in China
(WorldNews Belgium)
 


PharmaMar announces that lurbinectedin has received acceptance for its clinical trial application in China Madrid, June 29th, 2020.- PharmaMar (MSE:PHM) has announced today along with its partner in China, Luye Pharma Group Ltd., that the clinical trial application of lurbinectedin for Small Cell Lung Cancer (SCLC) has received formal acceptance from the Centre for Drug Evaluation (CDE) of the People`s Republic of China. With this acceptance, Luye Pharma is allowed to begin new clinical trials with lurbinectedin in the Chinese population, as this is a requirement of the regulatory authorities. In April 2019, PharmaMar and Luye Pharma entered into a license development and commercialization...


 
56 viewsCategory: General > Europe > Belgium
 
bp agrees to sell its petrochemicals business to INEOS
(WorldNews Belgium)
PharmaMar announces that it has received payment of $100 million from Jazz Pharmaceuticals for the approval of ZepzelcaTM (lurbinectedin) in the U.S.
(WorldNews Belgium)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2020 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten